Remote Blood Pressure Monitoring for High Blood Pressure in Pregnancy
(RBPM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study represents an innovative approach to hypertensive disorders of pregnancy surveillance by using remote blood pressure monitoring to address the unique challenges of hypertensive disorders of pregnancy management in a predominantly rural state. Transitioning from episodic in-clinic monitoring to continuous, patient-centered monitoring changes how high-risk patients and healthcare providers detect hypertensive episodes and advances the field by establishing clinical effectiveness and feasibility of remote blood pressure monitoring (RBPM), to provide evidence for scaling interventions that improve maternal health.
Who Is on the Research Team?
Peter VanEerden, MD
Principal Investigator
Sanford Health
Are You a Good Fit for This Trial?
This trial is for pregnant individuals with high blood pressure or preeclampsia. Participants should be able to use remote monitoring devices and follow instructions from their healthcare team.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Remote Blood Pressure Monitoring
Trial Overview
The study tests if using remote blood pressure monitors at home helps manage high blood pressure during pregnancy better than just checking it in the clinic. It focuses on safety, effectiveness, and ease of use.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Pregnant or newly postpartum women who are diagnosed with a hypertensive disorder of pregnancy and consent to monitor their blood pressures remotely.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sanford Health
Lead Sponsor
University of North Dakota
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.